These results are consistent with literature that suggests that overexpression of AXL promotes proliferation, migration and invasion whereas, genetic knockdown or pharmacological inhibition suppresses these phenotypes in various cancers20,28,29, including HNSCC and oral cancer30,31. The gene discussed is AXL; the disease is head and neck squamous cell carcinoma.